tradingkey.logo

Akari Therapeutics PLC

AKTX
0.267USD
+0.022+8.93%
Close 12/24, 13:00ETQuotes delayed by 15 min
8.71MMarket Cap
LossP/E TTM

Akari Therapeutics PLC Earnings Date

Period
FY2024 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-1.66
18.63%
Analyst Rating
BUY
2025-12-09

Financial Indicators

EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Income Statement

Revenue
Operating profit
Net Profit
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Balance Sheet

Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Cash Flow Statement

Net operating income
Net investment
Net financing
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

FAQs

What is the total revenue of Akari Therapeutics PLC?

According to Akari Therapeutics PLC's FY2024 earnings report, its total revenue reached --, with a year-on-year change of --.

What is the Earnings Per Share (EPS) of Akari Therapeutics PLC?

According to Akari Therapeutics PLC's FY2024 earnings report, its Earnings Per Share (EPS) was -1.660, with a year-on-year change of 18.63%.

What is the net income of Akari Therapeutics PLC?

According to Akari Therapeutics PLC's FY2024 earnings report, its net income was -19.79M, with a year-on-year change of -97.75%.

What is the net margin of Akari Therapeutics PLC?

According to Akari Therapeutics PLC's FY2024 earnings report, its net profit margin was --, with a year-on-year change of --.

What is the gross margin of Akari Therapeutics PLC?

According to Akari Therapeutics PLC's FY2024 earnings report, its gross margin was --, with a year-on-year change of --.

What is the debt-to-asset ratio of Akari Therapeutics PLC?

According to Akari Therapeutics PLC's FY2024 earnings report, its debt-to-asset ratio was 6.45%, with a year-on-year change of --.

What is the Return on Equity (ROE) of Akari Therapeutics PLC?

According to Akari Therapeutics PLC's FY2024 earnings report, its Return on Equity (ROE) was -179.92%, with a year-on-year change of 85.96%.

What is the Return on Assets (ROA) of Akari Therapeutics PLC?

According to Akari Therapeutics PLC's FY2024 earnings report, its Return on Assets (ROA) was -72.08%, with a year-on-year change of 34.51%.

What is the operating profit of Akari Therapeutics PLC?

According to Akari Therapeutics PLC's FY2024 earnings report, its operating profit was -17.93M, with a year-on-year change of 7.47%.

What are the current assets of Akari Therapeutics PLC?

According to Akari Therapeutics PLC's FY2024 earnings report, its current assets were 2.95M, with a year-on-year change of -32.00%.

What are the total assets of Akari Therapeutics PLC?

According to Akari Therapeutics PLC's FY2024 earnings report, its total assets of Akari Therapeutics PLC were 50.56M, with a year-on-year change of 1061.01%.

What are the total liabilities of Akari Therapeutics PLC?

According to Akari Therapeutics PLC's FY2024 earnings report, its total liabilities of Akari Therapeutics PLC were 28.33M, with a year-on-year change of 518.08%.

What is the total equity of Akari Therapeutics PLC?

According to Akari Therapeutics PLC's FY2024 earnings report, its total equity of Akari Therapeutics PLC was 22.23M, with a year-on-year change of 9806.99%.

What is the net operating income of Akari Therapeutics PLC?

According to Akari Therapeutics PLC's FY2024 earnings report, its net operating income of Akari Therapeutics PLC was -19.79M, with a year-on-year change of -97.75%.

What is the net investment of Akari Therapeutics PLC?

According to Akari Therapeutics PLC's FY2024 earnings report, its net investment of Akari Therapeutics PLC was 382.00K, with a year-on-year change of --.

What is the net financing of Akari Therapeutics PLC?

According to Akari Therapeutics PLC's FY2024 earnings report, its net financing of Akari Therapeutics PLC was 10.99M, with a year-on-year change of 56.52%.
KeyAI